Можливості комплексної терапії хронічної недостатності мозкового кровообігу у потерпілих внаслідок аварії на Чорнобильській АЕС

Materials on efficacy and tolerance of agent Nicerium 30 UNO in the patients who suffered from Chernobyl Nuclear Power Plant accident are presented. The medicine was administered to the patients with discirculatory encephalopathy of the I and II stage caused by ahterosclerosis of cerebral vessels and hypertensive disease. It is shown that inclusion of nicerium 30 UNO into therapy of patients with chronical insufficiency of cerebral circulation contributes to statistical improvement of indices of neuropsychological status and cerebral hemodynamics.